Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
All Stories

Technology

667 articles · sorted by newest first

AllAI & SocietyBig Tech & MarketsScience & SpaceCyber & Privacy

Latest in Technology

Latest in Technology
20 results
Technology 6/2/2026

How Massive Is The Layoff Quotient In 2026? From Meta To Oracle, India’s Tech Jobs Hit Over A Lakh As AI Reshapes The Workforce

The axe has fallen on over one lakh (100,000) tech jobs across India through late 2025 and early 2026, as global giants from Meta to Oracle significantly downsize their Indian operations. This unprecedented churn is a direct consequence of aggressive cost optimization mandates colliding with the accelerating deployment of Generative AI tools, fundamentally reshaping demand for tech skills.

Editorial Team1 min
How Massive Is The Layoff Quotient In 2026? From Meta To Oracle, India’s Tech Jobs Hit Over A Lakh As AI Reshapes The Workforce
Technology 6/2/2026

ATLAS tackles a new double-Higgs frontier - ATLAS Experiment at CERN

CERN's ATLAS experiment is aggressively accelerating its pursuit of the elusive double-Higgs boson production, a critical frontier poised to validate or shatter the Standard Model of particle physics. With High-Luminosity LHC (HL-LHC) data just years away, physicists are intensely scrutinizing existing Run 3 datasets, perfecting analysis techniques to directly measure the Higgs boson's self-coupling—a fundamental interaction that could reveal the universe's deepest secrets. This is not merely an incremental step; it is a direct probe into the fabric of electroweak symmetry breaking.

Editorial Team1 min
ATLAS tackles a new double-Higgs frontier - ATLAS Experiment at CERN
Technology 6/2/2026

‘Utter disregard for the risk to human life’: Florida sues OpenAI and Sam Altman over AI safety - The Conversation

Florida has launched a landmark lawsuit against OpenAI and its CEO, Sam Altman, alleging an "utter disregard for the risk to human life" in their pursuit of advanced AI. Filed by Florida Attorney General Ashley Moody, the suit claims OpenAI knowingly deployed its sophisticated generative AI models, including a hypothetical next-gen "Astra" system, without sufficient safety mechanisms despite internal warnings, directly endangering the public and particularly children.

Editorial Team1 min
‘Utter disregard for the risk to human life’: Florida sues OpenAI and Sam Altman over AI safety - The Conversation
Technology 6/2/2026

Many women with breast cancer could avoid chemotherapy — what you need to know about the genetic test - Down To Earth

Groundbreaking genomic assays, spearheaded by Veracyte's Prosigna test, are now routinely sparing tens of thousands more early-stage, hormone receptor-positive breast cancer patients from the debilitating side effects of chemotherapy. Recent clinical guideline updates, reflecting robust long-term data, solidify these tests as a critical tool, ensuring treatment de-escalation without compromising efficacy for those with favorable recurrence scores. This marks a significant shift in oncology, moving aggressively towards truly personalized medicine.

Editorial Team1 min
Many women with breast cancer could avoid chemotherapy — what you need to know about the genetic test - Down To Earth
Technology 6/2/2026

Google-parent Alphabet plans to raise $80 billion for AI goals; Berkshire to invest $10 billion

Google-parent Alphabet is set to supercharge its Artificial Intelligence ambitions with an audacious $80 billion equity offering, significantly bolstered by a $10 billion investment from Warren Buffett's Berkshire Hathaway. This massive capital injection signals a no-holds-barred commitment to winning the escalating AI arms race, a move poised to reshape both Alphabet's strategic trajectory and the broader tech landscape.

Editorial Team1 min
Google-parent Alphabet plans to raise $80 billion for AI goals; Berkshire to invest $10 billion
Technology 6/2/2026

Cybersecurity: The new core infrastructure of the UAE economy

A series of sophisticated drone strikes targeting Amazon Web Services (AWS) data centers in the UAE, coupled with a surge in AI-driven cyberattacks on banking and logistics networks, has jolted the Emirates into a radical redefinition of its national security posture. The coordinated assaults, attributed to advanced Hybrid Threat Actors, underscore a critical new vulnerability where physical and digital realms converge to threaten economic stability directly.

Editorial Team1 min
Cybersecurity: The new core infrastructure of the UAE economy
Technology 6/2/2026

Semaglutide Shows Early Potential in Reducing Nicotine Craving in Daily Smokers: Randomized Trial

The highly anticipated results of a Phase 2a randomized clinical trial, published recently in JAMA Network Open, indicate that once-weekly semaglutide significantly curtails nicotine craving and supports body weight reduction in daily smokers. This initial finding positions the blockbuster GLP-1 agonist, known for its efficacy in obesity and diabetes, as a surprising potential new weapon against smoking addiction, a major public health challenge.

Editorial Team1 min
Semaglutide Shows Early Potential in Reducing Nicotine Craving in Daily Smokers: Randomized Trial
Technology 6/2/2026

Anthropic Files S-1 Opening The IPO Floodgates, Analyst Says

Anthropic, a leading contender in the generative AI race, has confidentially submitted its Form S-1 to the SEC, firing the starting pistol on what Wedbush analyst Dan Ives dubs an "opening of the floodgates" for the long-dormant IPO market. This move not only puts the Claude AI developer on an immediate path to a public offering but also ignites a fierce sprint against rivals like OpenAI and SpaceX, who are also set to test public investor appetite in 2026.

Editorial Team1 min
Anthropic Files S-1 Opening The IPO Floodgates, Analyst Says
Technology 6/2/2026

Nvidia Releases Its Best Open AI Model Yet—But Still Lags Behind China - Decrypt

Nvidia has just unveiled Nemotron 3 Ultra, its most powerful open-source large language model, alongside the Cosmos 3 platform aimed at developing advanced "physical AI" and "world models" for robotics. While Nemotron 3 Ultra now ranks as the smartest open US model, benchmarks indicate it still trails behind leading Chinese open AI models in certain complex reasoning tasks and multimodal capabilities, underscoring the escalating US-China tech rivalry.

Editorial Team1 min
Nvidia Releases Its Best Open AI Model Yet—But Still Lags Behind China - Decrypt
Technology 6/2/2026

Australia Case Study: One-Stop Lithium Battery Pilot Line for University of Adelaide

Australia is making a decisive move to solidify its role beyond a mere raw materials supplier in the global battery ecosystem, with the University of Adelaide launching a new Lithium Battery Pilot Line. This state-of-the-art facility, commissioned by the Australian government, will produce up to 500 5Ah pouch cells daily, directly advancing sovereign capabilities in new energy battery research and development. It signals a critical step in domesticating sophisticated manufacturing processes, shifting from mining to high-value-added production.

Editorial Team1 min
Australia Case Study: One-Stop Lithium Battery Pilot Line for University of Adelaide
Technology 6/2/2026

SpaceX Mounts Surprise Push for 180-Day Phone Unlocking Rule

SpaceX has launched a surprising regulatory broadside at the FCC, formally petitioning the commission to mandate a 180-day unlocking period for carrier-locked mobile phones. This aggressive move directly targets incumbent wireless giants like T-Mobile, whose current 365-day policy significantly curtails consumer flexibility and access to the burgeoning direct-to-cell satellite market.

Editorial Team1 min
SpaceX Mounts Surprise Push for 180-Day Phone Unlocking Rule
Technology 6/2/2026

Why Google wants to release 32 million mosquitoes in California and Florida

Tech behemoth Google, through its parent company Alphabet, is poised to dramatically escalate its foray into public health, seeking immediate federal approval to release 32 million Wolbachia-infected mosquitoes across California and Florida. This ambitious expansion of its Debug Project, currently under review by the U.S. Environmental Protection Agency, aims to decimate populations of disease-carrying mosquitoes, with a public comment period closing on June 5, 2026.

Editorial Team1 min
Why Google wants to release 32 million mosquitoes in California and Florida
Technology 6/2/2026

Anthropic races toward a Wall Street debut with a confidential SEC filing

Anthropic, a leading contender in the generative AI space, has confidentially filed its S-1 registration statement with the Securities and Exchange Commission (SEC), signaling an imminent Initial Public Offering. This move, reportedly backed by recent funding rounds pushing its Valuation towards an astonishing $965 billion, positions the AI pioneer for one of the largest and most anticipated market debuts in recent memory, fundamentally reshaping the AI investment landscape.

Editorial Team1 min
Anthropic races toward a Wall Street debut with a confidential SEC filing
Technology 6/2/2026

OPTIMA Trial in Premenopausal Patients: Practice Implications - Docwire News

Groundbreaking results from the OPTIMA trial have confirmed that a significant subset of premenopausal women with hormone-receptor-positive, HER2-negative early breast cancer can safely forgo adjuvant chemotherapy. This landmark study, presented at major oncology forums in late 2025 and early 2026, leverages Veracyte's Prosigna genomic test to identify low-risk patients, potentially sparing millions from debilitating side effects without compromising survival outcomes.

Editorial Team1 min
OPTIMA Trial in Premenopausal Patients: Practice Implications - Docwire News
Technology 6/2/2026

Researchers advance first-of-its-kind AI tool for translating life-saving weather warnings across the US

Researchers led by Joseph Trujillo-Falcón have significantly advanced a first-of-its-kind AI tool, now reportedly nearing pilot deployment, that dynamically translates critical weather warnings into multiple non-English languages across the U.S. This breakthrough promises to drastically shorten the communication lag during emergencies, directly addressing a long-standing vulnerability for millions of non-English speaking residents as extreme weather events escalate.

Editorial Team1 min
Researchers advance first-of-its-kind AI tool for translating life-saving weather warnings across the US
Technology 6/1/2026

Sean Parker’s $250 million cancer bet that rewrote the rules of medical collaboration

The Parker Institute for Cancer Immunotherapy (PICI) has achieved a major milestone, announcing today that its collaborative model has accelerated a novel CAR T-cell therapy targeting aggressive solid tumors into the final stages of a multi-center Phase 3 clinical trial. This unprecedented speed, largely thanks to a decade of integrated genomic sequencing data and real-time sharing across its network of leading research institutions, positions the personalized treatment for an expedited FDA review as early as Q4 2026.

Editorial Team1 min
Sean Parker’s $250 million cancer bet that rewrote the rules of medical collaboration
Technology 6/1/2026

IPO-bound Cars24 launches Cars24 Labs, commits $20 million to AI products, startup investments

Cars24, the Indian used-car disruptor, has launched "Cars24 Labs" backed by a $20 million war chest, signaling a significant escalation in its AI arms race. This strategic move, designed to supercharge its platform with advanced artificial intelligence and foster external tech partnerships, comes as the company navigates choppy waters towards a potential late-2026 IPO.

Editorial Team1 min
IPO-bound Cars24 launches Cars24 Labs, commits $20 million to AI products, startup investments
Technology 6/1/2026

Uncle Sam Is Buying Into Quantum Computing Stocks. Should You?

The U.S. government is dramatically escalating its direct investment in quantum computing firms, funneling billions through defense contracts and strategic venture capital arms in a concerted effort to win the global quantum race, particularly against China. Recent directives from the Department of Defense (DoD) and intelligence agencies are prioritizing equity stakes and long-term procurement agreements with nascent quantum hardware and software developers, moving beyond traditional R&D grants to secure early access and influence over this foundational technology.

Editorial Team1 min
Uncle Sam Is Buying Into Quantum Computing Stocks. Should You?
Technology 6/1/2026

Pharmacogenomics in 2026: From Research Concept to Clinical Workflow

Pharmacogenomics has officially left the lab bench, transitioning from niche research to a central pillar of clinical practice in 2026. Major healthcare systems, spearheaded by institutions like Mayo Clinic and Vanderbilt, are now routinely integrating germline genetic data into electronic health records to guide prescribing decisions, effectively reducing adverse drug reactions and boosting therapeutic efficacy across oncology, cardiology, and psychiatry. This systemic shift is being driven by maturing interoperability standards and advanced clinical decision support systems.

Editorial Team1 min
Pharmacogenomics in 2026: From Research Concept to Clinical Workflow
Technology 6/1/2026

Hengrui Pharma Presents More Than 90 Oncology Studies at ASCO 2026, Highlighting Progress Across Multiple Tumor Types

Hengrui Pharma, a major player in China's burgeoning biopharmaceutical sector, unveiled an impressive 91 oncology studies at the ASCO 2026 Annual Meeting in Chicago, showcasing significant clinical progress across a broad spectrum of cancers. Notably, data from trials like HELEN-Trio 011 for triple-negative breast cancer and HORIZON-CRC01 for HER2-positive colorectal cancer reported compelling improvements in pathological complete response and progression-free survival, respectively, signaling potential shifts in treatment paradigms.

Editorial Team1 min
Hengrui Pharma Presents More Than 90 Oncology Studies at ASCO 2026, Highlighting Progress Across Multiple Tumor Types
‹ Prev1…2223242526…34Next ›

Page 24 of 34 · 667 articles

ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies